-
FDA Inspections of Outsourcing Facilities
FDA
March 31, 2022
Provide an overview of the inspection process for compounding outsourcing facilities.
-
CPhI Monthly Podcast: Selecting the Right CDMO Outsourcing Partner
cphi-online
September 13, 2021
Sponsors within the biopharmaceutical industry are increasingly turning to outsourcing for several reasons; remaining competitive and flexible within a quickly evolving sector...
-
Pandemic and transformative technologies fuel growth in pharma outsourcing sector: CPhI North America panel
cphi-online
July 28, 2021
Transformative technologies and the opportunities afforded by the COVID-19 pandemic have spurred investment in the life sciences outsourcing sector, according to a panel of industry experts speaking at CPhI North America on Monday.
-
Biotech and pharma services outsourcing market to be worth over $91bn by 2028
europeanpharmaceuticalreview
April 14, 2021
A new report suggests the global biotechnology and pharmaceutical services outsourcing market will grow because of the pandemic and rising drug development costs and R&D investments.
-
FDA proposes four APIs for bulk substances list for outsourcing facilities
europeanpharmaceuticalreview
August 03, 2020
Four APIs are being considered by the FDA for its bulk drug substances list for potential use by outsourcing facilities when compounding if there is a clinical need.
-
FDA new drug approvals down 16 percent in 2019, impacting outsourcing
europeanpharmaceuticalreview
May 14, 2020
A new report has found that in 2019 the FDA approved 119 new drugs and biologics, but that this is down from 137 in 2018, impacting contract manufacturing organisations.
-
UK vaccine clinical trial outsourcing expansion continues
europeanpharmaceuticalreview
May 05, 2020
An outsourcing company has announced that Phase II, III and IV clinical trials of vaccines will continue at a growing number of sites, assessing the safety of each in light of COVID-19.
-
Pharmacovigilance and drug safety outsourcing worth $207.7M by 2024
europeanpharmaceuticalreview
October 25, 2018
Outsourcing has become more popular with pharmaceutical companies, and has led to work being completed quicker, with less effort and cost involved…
-
Drug discovery outsourcing market forecast 2017-2025
europeanpharmaceuticalreview
October 24, 2018
A market report has given a complete backdrop analysis of the pharmaceutical drug discovery outsourcing market, including market growth and shares…
-
Outsourcing aids microbiology testing market to grow at 6.4% CAGR by 2023
europeanpharmaceuticalreview
July 16, 2018
The global clinical microbiology market is projected to reach USD 4.95bn by 2023 from USD 3.63bn in 2018, growing at a CAGR of 6.4% from 2018 to 2023.